Search Results 1391-1400 of 18725 for Relapse
... Relapsed FHWT. Rochester, Minn. The purpose of this study is to evaluate how ... (relapsed). Drugs used in chemotherapy regimens such as UH-3 ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or ...
Learn how doctors use this blood test to measure levels of a tumor marker associated with ovarian cancer, fallopian tube cancer and other types of cancer.
Patients at high risk of relapse are eligible for InPACT-pelvis, where they ... A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory ...
... relapsed pediatric leukemia. Ann Hematol. 2016 Mar; 95 (4):637-44 Epub 2016 Jan 20. View PubMed; Habibi S, Jenkins C, Natt B. Medical image of the week ...
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...
Currently, six different CAR -T cell therapies are approved for treating relapsed blood cancers. Most patients have impressive response rates, but not ...
This medicine will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.